LLY
988.33
+0.72%↑
JNJ
240.32
+0.33%↑
ABBV
229.95
-0.9%↓
NVS
159.76
-0.49%↓
AZN
194.37
-1.51%↓
LLY
988.33
+0.72%↑
JNJ
240.32
+0.33%↑
ABBV
229.95
-0.9%↓
NVS
159.76
-0.49%↓
AZN
194.37
-1.51%↓
LLY
988.33
+0.72%↑
JNJ
240.32
+0.33%↑
ABBV
229.95
-0.9%↓
NVS
159.76
-0.49%↓
AZN
194.37
-1.51%↓
LLY
988.33
+0.72%↑
JNJ
240.32
+0.33%↑
ABBV
229.95
-0.9%↓
NVS
159.76
-0.49%↓
AZN
194.37
-1.51%↓
LLY
988.33
+0.72%↑
JNJ
240.32
+0.33%↑
ABBV
229.95
-0.9%↓
NVS
159.76
-0.49%↓
AZN
194.37
-1.51%↓
24h
Current
Min
4.46
Max
4.63
Income | -269K -8.7M |
|---|---|
EPS | -0.07 |
Employees | 15 |
EBITDA | 348K -8.7M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +1369.02% upside |
Market Cap | 39M |
|---|---|
Previous open | 6.67 |
Previous close | 4.5 |
By Trading Central
Confidence
Bullish Evidence
0.7955 / 0.898 Support & Resistance
Past performance is not a reliable indicator of future results.
16 Jan 2026, 23:29 UTC
Stocks to Watch: Atossa Therapeutics, Union Pacific
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 68.75 USD 1369.02%
High 120 USD
Low 10 USD
Based on 4 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
4 ratings
4
Buy
0
Hold
0
Sell
Based on 4 analysts giving stock ratings to Atossa Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Weak Bearish Evidence
There is one bearish event.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$